Skip to content
Parakho

Solara Active Pharma Sciences Ltd

NSE SOLARABSE 541540solara.co.inInvestor relations

Q2 FY27, unaudited

Revenue
₹417.34 Cr
Profit after tax
₹28.46 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ2 FY27vs a year ago6M FY27
Revenue from operations417.34+33.11%798.94
Other income0.54+10.20%3.23
Total income417.88+33.07%802.17
Employee benefit expense57.62+5.03%113.67
Finance costs17.78−14.64%39.42
Depreciation & amortisation26.64+8.78%53.35
Total expenses384.92+18.75%752.90
Profit before tax28.46+381.78%44.77
Tax expense0.00—0.00
Profit after tax28.46+381.78%44.77
Total comprehensive income28.59+407.75%44.85
Earnings per share
Earnings per share, basic₹5.92₹9.49
Earnings per share, diluted₹5.92₹9.49

Q2 FY27 and 6M FY27 — unaudited, from the company’s filing with NSE. Source

Q2 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

Q2 FY27 results for every company Parakho holds

Earnings call

Q1 FY27

Solara Active Pharma Sciences reported Q1 FY27 revenue of INR384 crores, up 20% year-on-year, with EBITDA of INR63.5 crores and PAT of INR16.3 crores, which management said were the highest EBITDA and PAT in 18 quarters. The base business grew 24% year-on-year while the commodity Ibuprofen business reported a negative 12% EBITDA margin amid raw material cost pressures linked to the West Asia crisis. Management also reported a reduction in net debt of roughly INR135 crores during the quarter, bringing net debt to approximately INR479 crores.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote.

Read the full summary

Earlier calls: Q4 FY26 · All quarters

Filings

12 shown · 63 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Healthcare › Pharmaceuticals

Classification as published by BSE.

Companies also in Pharmaceuticals, in alphabetical order

All 196 companies in Pharmaceuticals

Page generated from filings held to 10 Oct 2026.